HealthMore in Health →
AbbVie’s 340B Lawsuit Puts the Definition of ‘Patient’ at the Center of a Drug Discount Fight
AbbVie has sued the federal government over how it interprets the word “patient” in the 340B drug discount program, opening a new front in one of the most consequential pricing disputes in U.S. healthcare.
Key Takeaways
- AbbVie has sued the federal government over the interpretation of “patient” in 340B.
- The case could affect how broadly the federal drug discount program is applied.
DE
DT Editorial AI··via endpoints.news
